Literature DB >> 29468424

Full depth measurement of tenofovir transport in rectal mucosa using confocal Raman spectroscopy and optical coherence tomography.

Aubrey L Presnell1, Oranat Chuchuen2,3, Morgan G Simons1, Jason R Maher1, David F Katz4,5.   

Abstract

The prophylactic activity of antiretroviral drugs applied as microbicides against sexually transmitted HIV is dependent upon their concentrations in infectable host cells. Within mucosal sites of infection (e.g., vaginal and rectal mucosa), those cells exist primarily in the stromal layer of the tissue. Traditional pharmacokinetic studies of these drugs have been challenged by poor temporal and spatial specificity. Newer techniques to measure drug concentrations, involving Raman spectroscopy, have been limited by laser penetration depth into tissue. Utilizing confocal Raman spectroscopy (RS) in conjunction with optical coherence tomography (OCT), a new lateral imaging assay enabled concentration distributions to be imaged with spatial and temporal specificity throughout the full depth of a tissue specimen. The new methodology was applied in rectal tissue using a clinical rectal gel formulation of 1% tenofovir (TFV). Confocal RS revealed diffusion-like behavior of TFV through the tissue specimen, with significant partitioning of the drug at the interface between the stromal and adipose tissue layers. This has implications for drug delivery to infectable tissue sites. The new assay can be applied to rigorously analyze microbicide transport and delineate fundamental transport parameters of the drugs (released from a variety of delivery vehicles) throughout the mucosa, thus informing microbicide product design.

Entities:  

Keywords:  Drug delivery; Microbicides; Optical coherence tomography; Raman spectroscopy; Rectal mucosa; Tenofovir

Mesh:

Substances:

Year:  2018        PMID: 29468424      PMCID: PMC6042643          DOI: 10.1007/s13346-018-0495-7

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  39 in total

Review 1.  FRAP in pharmaceutical research: practical guidelines and applications in drug delivery.

Authors:  Hendrik Deschout; Koen Raemdonck; Jo Demeester; Stefaan C De Smedt; Kevin Braeckmans
Journal:  Pharm Res       Date:  2013-09-10       Impact factor: 4.200

2.  Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels.

Authors:  Ahmed S Zidan; Muhammad J Habib
Journal:  J Pharm Sci       Date:  2014-01-24       Impact factor: 3.534

3.  Per-contact risk of human immunodeficiency virus transmission between male sexual partners.

Authors:  E Vittinghoff; J Douglas; F Judson; D McKirnan; K MacQueen; S P Buchbinder
Journal:  Am J Epidemiol       Date:  1999-08-01       Impact factor: 4.897

4.  Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women.

Authors:  Annalene M Nel; Paul Coplan; Shanique C Smythe; Karen McCord; Mark Mitchnick; Paulina E Kaptur; Joseph Romano
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-21       Impact factor: 2.205

5.  Using modeling to help understand vaginal microbicide functionality and create better products.

Authors:  David F Katz; Yajing Gao; Meng Kang
Journal:  Drug Deliv Transl Res       Date:  2011-05-17       Impact factor: 4.617

6.  Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: species- and region-related differences.

Authors:  P Nejdfors; M Ekelund; B Jeppsson; B R Weström
Journal:  Scand J Gastroenterol       Date:  2000-05       Impact factor: 2.423

7.  Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV.

Authors:  B Leynaert; A M Downs; I de Vincenzi
Journal:  Am J Epidemiol       Date:  1998-07-01       Impact factor: 4.897

8.  A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.

Authors:  Jill L Schwartz; Wes Rountree; Angela D M Kashuba; Vivian Brache; Mitchell D Creinin; Alfred Poindexter; Brian P Kearney
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

9.  Quantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal Raman spectroscopy.

Authors:  Oranat Chuchuen; Marcus H Henderson; Craig Sykes; Min Sung Kim; Angela D M Kashuba; David F Katz
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

10.  Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.

Authors:  Oranat Chuchuen; Jason R Maher; Marcus H Henderson; Michael Desoto; Lisa C Rohan; Adam Wax; David F Katz
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

View more
  4 in total

1.  Optical coherence tomography-guided confocal Raman microspectroscopy for rapid measurements in tissues.

Authors:  Xiaojing Ren; Kan Lin; Chao-Mao Hsieh; Linbo Liu; Xin Ge; Quan Liu
Journal:  Biomed Opt Express       Date:  2021-12-14       Impact factor: 3.732

2.  A Molecular Study of Aspirin and Tenofovir Using Gold/Dextran Nanocomposites and Surface-Enhanced Raman Spectroscopy.

Authors:  Setumo Lebogang Thobakgale; Saturnin Ombinda-Lemboumba; Patience Mthunzi-Kufa
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

3.  Morpho-molecular signal correlation between optical coherence tomography and Raman spectroscopy for superior image interpretation and clinical diagnosis.

Authors:  Iwan W Schie; Fabian Placzek; Florian Knorr; Eliana Cordero; Lara M Wurster; Gregers G Hermann; Karin Mogensen; Thomas Hasselager; Wolfgang Drexler; Jürgen Popp; Rainer A Leitgeb
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

4.  Rapid label-free analysis of Opisthorchis viverrini eggs in fecal specimens using confocal Raman spectroscopy.

Authors:  Oranat Chuchuen; Thani Thammaratana; Oranuch Sanpool; Rutchanee Rodpai; Wanchai Maleewong; Pewpan M Intapan
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.